Placebo (insulin glargine)

DRUG2 trials

Sponsors

Novo Nordisk A/S

Conditions

Diabetes Mellitus, Type 2

Phase 1

A Clinical Study to Compare the Efficacy and Safety of a Novel Medicine (NNC0268-0965) With Insulin Glargine

CompletedNCT04575181

Novo Nordisk A/SDiabetes Mellitus, Type 2

Start: 2020-10-21End: 2021-12-24Updated: 2024-01-10

Phase 2

A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Units/mL) Once a Day in People With Type 2 Diabetes.

CompletedNCT03751657

Novo Nordisk A/SDiabetes Mellitus, Type 2

Start: 2018-11-29End: 2020-01-17Updated: 2021-04-02

Related Papers

Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment

New England Journal of Medicine2020-09-22201 citations